Science Valley Research Institute   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: São Paulo Brazil (2015)

Organization Overview

First Clinical Trial
2020
NCT04229264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

André Luiz Malavasi Longo de Oliveira | Samantha Rodrigues Camargo Neves de Moura | Science Valley Research Institute | Tânia Portella Costa